2020
DOI: 10.1016/j.colsurfb.2020.110961
|View full text |Cite
|
Sign up to set email alerts
|

Bacterioruberin from Haloarchaea plus dexamethasone in ultra-small macrophage-targeted nanoparticles as potential intestinal repairing agent

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 42 publications
(48 reference statements)
1
9
0
Order By: Relevance
“…In addition, nebulized nATC reduced the levels of IL-6, and remarkably, surpassed the effect of nebulized dexamethasone, reducing the levels of IL-8. Similar repairing activity of archaeolipids on inflamed intestinal epithelia models have been described recently [ 67 ].…”
Section: Discussionsupporting
confidence: 75%
“…In addition, nebulized nATC reduced the levels of IL-6, and remarkably, surpassed the effect of nebulized dexamethasone, reducing the levels of IL-8. Similar repairing activity of archaeolipids on inflamed intestinal epithelia models have been described recently [ 67 ].…”
Section: Discussionsupporting
confidence: 75%
“…Haloarchaea produces carotenoids in high amounts that act as antioxidants, light protection pigments, and membrane stabilizers (Rodrigo-Banos et al, 2015;Giani et al, 2019). Bacterioruberin, a haloarchaeal carotenoid, reportedly has more free radical scavenging activity compared to plant β-carotenes, being used in various food and cosmetic products (Yatsunami et al, 2014;Higa et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…cancer cells. On the other hand, C 50 carotenoid bacterioruberin with dexamethasone reduced the release of TNF-α and IL-8, reversed the inflammation-induced morphological changes of macrophage, and had a potential role as an intestinal barrier repairing agent (Higa et al, 2020).…”
Section: Anticancer Compoundsmentioning
confidence: 97%